These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12609221)

  • 1. Adjunctive clinical trials in epilepsy: is a placebo arm necessary?
    Beydoun A; Kutluay E
    Epilepsy Behav; 2003 Feb; 4(1):4-5. PubMed ID: 12609221
    [No Abstract]   [Full Text] [Related]  

  • 2. Placebo effect in antiepileptic drug trials.
    Burneo JG; Montori VM; Faught E
    Epilepsy Behav; 2003 Jun; 4(3):371. PubMed ID: 12791346
    [No Abstract]   [Full Text] [Related]  

  • 3. The enigma of placebo effects in drug-refractory epilepsies.
    Krämer G
    Epilepsia; 2013 May; 54 Suppl 2():13-5. PubMed ID: 23646964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epilepsy in infancy: answering the call.
    Thio LL; Dodson WE
    Neurology; 2010 Mar; 74(9):708-9. PubMed ID: 20107140
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials.
    Ryvlin P; Cucherat M; Rheims S
    Lancet Neurol; 2011 Nov; 10(11):961-8. PubMed ID: 21937278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing placebo exposure in trials: Considerations from the Research Roundtable in Epilepsy.
    Fureman BE; Friedman D; Baulac M; Glauser T; Moreno J; Dixon-Salazar T; Bagiella E; Connor J; Ferry J; Farrell K; Fountain NB; French JA
    Neurology; 2017 Oct; 89(14):1507-1515. PubMed ID: 28878049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis.
    Beyenburg S; Stavem K; Schmidt D
    Epilepsia; 2010 Jan; 51(1):7-26. PubMed ID: 19744114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of randomized trials on first line and adjunctive levetiracetam.
    Lo BW; Kyu HH; Jichici D; Upton AM; Akl EA; Meade MO
    Can J Neurol Sci; 2011 May; 38(3):475-86. PubMed ID: 21515509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of patients with epilepsy included in clinical trials.
    Tlusta E; Handoko KB; Majoie M; Egberts TC; Vlcek J; Heerdink ER
    Epilepsia; 2008 Aug; 49(8):1479-80. PubMed ID: 18754945
    [No Abstract]   [Full Text] [Related]  

  • 10. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: reply to Beyenburg et al., 2009.
    Rheims S; Perucca E; Ryvlin P
    Epilepsia; 2010 May; 51(5):935-6. PubMed ID: 20536532
    [No Abstract]   [Full Text] [Related]  

  • 11. Placebo and nocebo responses in drug trials of epilepsy.
    Zaccara G; Giovannelli F; Schmidt D
    Epilepsy Behav; 2015 Feb; 43():128-34. PubMed ID: 25703333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do anticonvulsants alter the natural course of epilepsy? Case for early treatment is not established.
    Chadwick D
    BMJ; 1995 Jan; 310(6973):177-8. PubMed ID: 7833761
    [No Abstract]   [Full Text] [Related]  

  • 13. Levetiracetam: a new therapeutic option for refractory epilepsy.
    Pinto A; Sander JW
    Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo responses in randomized trials of antiepileptic drugs.
    Guekht AB; Korczyn AD; Bondareva IB; Gusev EI
    Epilepsy Behav; 2010 Jan; 17(1):64-9. PubMed ID: 19919904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan.
    Mizuguchi M; Ikeda H; Kagitani-Shimono K; Yoshinaga H; Suzuki Y; Aoki M; Endo M; Yonemura M; Kubota M
    Brain Dev; 2019 Jan; 41(1):1-10. PubMed ID: 30060984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of cannabinoids in paediatric epilepsy.
    Ali S; Scheffer IE; Sadleir LG
    Dev Med Child Neurol; 2019 Jan; 61(1):13-18. PubMed ID: 30402932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis.
    Rheims S; Perucca E; Cucherat M; Ryvlin P
    Epilepsia; 2011 Feb; 52(2):219-33. PubMed ID: 21269281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic prescribing for epilepsy. Is it safe?
    Beach R; Reading R
    Seizure; 1997 Aug; 6(4):327. PubMed ID: 9304726
    [No Abstract]   [Full Text] [Related]  

  • 19. Lacosamide for the treatment of epilepsy.
    Krauss GL; Edwards HB; Lin B
    Ann Med; 2012 Nov; 44(7):674-9. PubMed ID: 22380697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Historical control monotherapy design in the treatment of epilepsy.
    French JA; Wang S; Warnock B; Temkin N
    Epilepsia; 2010 Oct; 51(10):1936-43. PubMed ID: 20561024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.